1. Incidence of Tuberculosis During the First Year of Antiretroviral Treatment in West African HIV-Infected Adults
- Author
-
Olivier Marcy, Eric Balestre, Denise Hawerlander, François Dabis, Armel Poda, Eugène Messou, Patrick A. Coffie, Louise Fortes Deguenonvo, Albert Minga, Boris Tchakounte Youngui, Bordeaux population health (BPH), and Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
antiretroviral treatment ,Tuberculosis ,030231 tropical medicine ,IDLIC ,03 medical and health sciences ,0302 clinical medicine ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Hiv infected ,West Africa ,Antiretroviral treatment ,medicine ,030212 general & internal medicine ,Low hemoglobin ,Tuberculosis incidence ,2. Zero hunger ,business.industry ,Incidence (epidemiology) ,Brief Report ,HIV ,medicine.disease ,3. Good health ,West african ,Young age ,Infectious Diseases ,AcademicSubjects/MED00290 ,Oncology ,tuberculosis ,[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology ,incidence ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business ,Demography - Abstract
We estimated tuberculosis incidence during the first year on antriretroviral therapy without isoniazid-preventive treatment in 6938 West African HIV-infected adults at 3.33 cases per 100 person-years (95% CI, 2.85–3.80). In multivariate Poisson models, sites in Cote d’Ivoire, male gender, low body mass index, low hemoglobin, low CD4 count, and young age were significantly associated with higher incidence.
- Published
- 2020
- Full Text
- View/download PDF